Extended sensitivity of microfluidic immunoassays for pharmacokinetic (PK) and biomarker analysis


The use of ligand-binding assays in biotherapeutic development is a mainstay of analytical groups in biopharma companies. Since its introduction, the compact disk (CD) based, nanoliter-scale Gyrolab® microfluidic immunoassay platform has been widely accepted as an essential analytical technology due to its time-saving, automated, and robust performance. The success of the assay format centers around the microfluidic CD labware where the immunoassay takes place. Recently, the Gyrolab Bioaffy™ 4000 CD has been introduced to increase assay sensitivity 2- to 6-fold beyond the current 6-log dynamic range. In this poster, we present data pharmacokinetic (PK) and biomarker analysis down to low pg/mL levels with the Gyrolab Bioaffy 4000 CD demonstrating the sensitivity expansion of Gyrolab immunoassays facilitated with the new CD labware.


If you have problems downloading the poster please contact


Please register to dowload the poster